Thermo Fisher Scientific Inc.
TMO· NYSE
TMOThermo Fisher Scientific Inc.
Filed Feb 25, 2021 · 10-K · 56 days after period end · 0000097745-21-000011
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019 | Q4 2018 | Q4 2017 |
|---|---|---|---|---|
| Revenue | $10.55B | $6.83B | $6.51B | $6.05B |
| EPS Diluted | — | $2.49 | $2.22 | $1.30 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Feb 25, 2021 · 56 d after period end
